| Identification | More | [Name]
1H-Benzimidazole-5-carboxylic acid | [CAS]
15788-16-6 | [Synonyms]
1H-BENZIMIDAZOLE-5-CARBOXYLIC ACID 1H-BENZOIMIDAZOLE-5-CARBOXYLIC ACID 5-BENZIMIDAZOLECARBOXYLIC ACID 5-CARBOXYBENZIMIDAZOLE AKOS BBS-00000435 AURORA 9842 BENZIMIDAZOLE-5-CARBOXYLIC ACID BENZOIMIDAZOLE-5-CARBOXYLIC ACID OTAVA-BB BB7014211630 3H-benzo[d]imidazole-5-carboxylic acid 1H-Benzimidazole-5-carboxylicacid(9CI) 5-Carboxylic Acid Benzimidazole 1H-Benzimadazole-5-carboxylic acid 1H-benzimidazole-6-carboxylic acid 1H-Benzoimidazole-6-carboxylic acid | [Molecular Formula]
C8H6N2O2 | [MDL Number]
MFCD00011555 | [Molecular Weight]
162.15 | [MOL File]
15788-16-6.mol |
| Chemical Properties | Back Directory | [Appearance]
GREEN-GREY TO GREY-BROWN POWDER | [Melting point ]
>300 °C (lit.) | [Boiling point ]
288.82°C (rough estimate) | [density ]
1.3264 (rough estimate) | [refractive index ]
1.5770 (estimate) | [storage temp. ]
Keep in dark place,Sealed in dry,Room Temperature | [solubility ]
DMSO (Slightly), Methanol (Slightly, Heated) | [form ]
Powder | [pka]
3.10±0.30(Predicted) | [color ]
Green-gray to gray-brown | [BRN ]
5686 | [InChI]
InChI=1S/C8H6N2O2/c11-8(12)5-1-2-6-7(3-5)10-4-9-6/h1-4H,(H,9,10)(H,11,12) | [InChIKey]
COYPLDIXZODDDL-UHFFFAOYSA-N | [SMILES]
C1NC2=CC(C(O)=O)=CC=C2N=1 | [CAS DataBase Reference]
15788-16-6(CAS DataBase Reference) |
| Safety Data | Back Directory | [Hazard Codes ]
Xi | [Risk Statements ]
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice . S37/39:Wear suitable gloves and eye/face protection . | [WGK Germany ]
3
| [HazardClass ]
IRRITANT | [HS Code ]
29339900 |
| Hazard Information | Back Directory | [Chemical Properties]
GREEN-GREY TO GREY-BROWN POWDER | [Uses]
5-Benzimidazolecarboxylic acid has been used in the preparation of:
- 1H-benzoimidazole-5-carboxylic acid benzotriazol-1-yl ester
- piperidin-1-yl(1-m-tolyl-1H-benzo[d]imidazol-5-yl)methanone
| [Uses]
A benzimidazole derivative that exhibits corrosion inhibiting properties against strong acids. | [General Description]
Drug-specific monoclonal antibodies were produced against the very small drug hapten, 5-benzimidazolecarboxylic acid. | [Synthesis]
To a solution of 5-bromo-1H-benzimidazole (0.87 g, 4.4 mmol, 1.0 eq.) in anhydrous THF (20 mL) was slowly added 2 M isopropylmagnesium chloride (i-PrMgCl) in a solution of THF (2.2 mL, 4.4 mmol, 1.0 eq.) at 0 °C, keeping the reaction temperature not more than 20 °C. After addition, the clarified solution was continued to be stirred at 0 °C for 5 min. Subsequently, 2.5 M hexane solution (3.5 mL, 8.8 mmol, 2.0 eq.) of n-butyllithium (n-BuLi) was added dropwise over 5 min, controlling the temperature below 20 °C. The reaction mixture was stirred at the same temperature for 30 min. Then, dry carbon dioxide (0.20 g, 4.4 mmol, 1.0 eq.) was added to the reaction system and the mixture was slowly warmed to 20 °C over 30 min. Upon completion of the reaction, the reaction was quenched with deionized water (6 mL). After stirring at 20 °C for 10 min, the organic and aqueous phases were separated. The aqueous phase was extracted once with ethyl acetate (10 mL). The organic phases were combined, filtered through a 0.51 cm silica gel pad and eluted with ethyl acetate (10 mL). The filtrate was concentrated and the residue was purified by silica gel column chromatography (eluent: petroleum ether/ethyl acetate = 3:1) to afford 1H-benzimidazole-5-carboxylic acid (0.5 g, 71% yield) as a brown solid. The product was structurally confirmed by 1H-NMR (600 MHz, DMSO-d6) and 13C-NMR (151 MHz, DMSO-d6). | [References]
[1] Molecules, 2017, vol. 22, # 11, |
|
|